The Saudi Arabia Continuous Glucose Monitoring Market was valued at USD 92.2 million in 2024 and is estimated to grow at a CAGR of 16.1% to reach USD 344.2 million by 2034.
Saudi Arabia has one of the highest diabetes prevalence rates globally, with Type 2 diabetes affecting a significant portion of the adult population. This growing burden is driving strong demand for effective glucose monitoring tools, making CGM systems a critical component in diabetes management.
Major players in the Saudi Arabia continuous glucose monitoring market are MedTrust, Abbott Laboratories, Sinocare, Dexcom, A. Menarini Diagnostics, and Medtronic.
To strengthen their presence in the Saudi Arabia Continuous Glucose Monitoring (CGM) market, leading companies are focusing on a mix of local partnerships, awareness campaigns, product localization, and regulatory engagement. Collaborations with healthcare providers, clinics, and diabetes centers are helping manufacturers improve device accessibility and build trust among patients. Firms are also investing in public and physician education programs to increase awareness about the clinical benefits of CGM over traditional glucose monitoring methods. Additionally, companies are working with regulatory authorities to accelerate device approvals and align with Saudi FDA standards. Localization strategies, including Arabic-language interfaces and region-specific app features, are being used to enhance user engagement. Furthermore, insurance collaboration efforts are underway to expand reimbursement coverage, making CGM technology more affordable and appealing to a broader patient base.
This product will be delivered within 2-4 business days.
Saudi Arabia has one of the highest diabetes prevalence rates globally, with Type 2 diabetes affecting a significant portion of the adult population. This growing burden is driving strong demand for effective glucose monitoring tools, making CGM systems a critical component in diabetes management.
Growing Adoption of CGM Sensors
The sensors segment in the Saudi Arabia continuous glucose monitoring market accounted for a significant share in 2024. These sensors are essential for capturing real-time glucose levels from interstitial fluid and transmitting accurate data to devices or smartphone applications. As users seek enhanced comfort, longer wear duration, and minimal calibration requirements, manufacturers are focusing on advancing sensor technology. Innovations such as extended wear sensors, flexible materials, and pre-calibrated solutions are fueling this segment’s expansion. The upward trend underscores a broader movement toward user convenience, particularly for individuals managing diabetes outside of traditional healthcare facilities.Increasing shifts toward home care settings
The home care segment is expected to experience steady growth between 2025 and 2034, driven by a rising preference for remote monitoring and self-managed care. Patients are increasingly turning to CGM systems to track glucose levels in real time from the comfort of their homes. These systems not only support daily disease management but also enable seamless data sharing with healthcare providers and family members through connected digital platforms. This trend is minimizing the need for frequent clinical visits and empowering individuals to take a more proactive and independent role in their diabetes care.Major players in the Saudi Arabia continuous glucose monitoring market are MedTrust, Abbott Laboratories, Sinocare, Dexcom, A. Menarini Diagnostics, and Medtronic.
To strengthen their presence in the Saudi Arabia Continuous Glucose Monitoring (CGM) market, leading companies are focusing on a mix of local partnerships, awareness campaigns, product localization, and regulatory engagement. Collaborations with healthcare providers, clinics, and diabetes centers are helping manufacturers improve device accessibility and build trust among patients. Firms are also investing in public and physician education programs to increase awareness about the clinical benefits of CGM over traditional glucose monitoring methods. Additionally, companies are working with regulatory authorities to accelerate device approvals and align with Saudi FDA standards. Localization strategies, including Arabic-language interfaces and region-specific app features, are being used to enhance user engagement. Furthermore, insurance collaboration efforts are underway to expand reimbursement coverage, making CGM technology more affordable and appealing to a broader patient base.
Comprehensive Market Analysis and Forecast
- Industry trends, key growth drivers, challenges, future opportunities, and regulatory landscape
- Competitive landscape with Porter’s Five Forces and PESTEL analysis
- Market size, segmentation, and regional forecasts
- In-depth company profiles, business strategies, financial insights, and SWOT analysis
This product will be delivered within 2-4 business days.
Table of Contents
Chapter 1 Methodology and Scope
Chapter 2 Executive Summary
Chapter 3 Industry Insights
Chapter 4 Competitive Landscape, 2024
Chapter 5 Market Estimates and Forecast, by Component, 2021-2034 ($ Mn)
Chapter 6 Market Estimates and Forecast, by End Use, 2021-2034 ($ Mn)
Chapter 7 Company Profiles
Companies Mentioned
The key companies profiled in this Saudi Arabia Continuous Glucose Monitoring market report include:- Abbott Laboratories
- A. Menarini Diagnostics
- Dexcom
- Med Trust
- Medtronic
- Sinocare
